Hims & Hers Health (HIMS) Tax Provisions (2020 - 2026)
Hims & Hers Health (HIMS) posted Tax Provisions of -$9.4 million for Q1 2026, down 319.75% sequentially from -$2.2 million in Q4 2025, and down 185.7% YoY from $11.0 million in Q1 2025.
Hims & Hers Health (HIMS) Tax Provisions (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Tax Provisions for 7 years, with the latest figure at -$9.4 million in Q1 2026.
- Quarterly Tax Provisions fell 185.7% year-over-year to -$9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.9 million (up 44.19% YoY) and the FY2025 annual result came in at -$4.4 million, up 91.83% from the prior year.
- Tax Provisions eased to -$9.4 million in Q1 2026 per HIMS's latest filing, from -$2.2 million in the prior quarter.
- Over five years, Tax Provisions peaked at $11.0 million in Q1 2025 and troughed at -$52.0 million in Q3 2024.
- A 5-year average of -$3.9 million and a median of -$13000.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions jumped 4168.75% in 2023, then plunged 8086.94% in 2024.
- Over 5 years, Tax Provisions stood at -$121000.0 in 2022, then surged by 885.95% to $951000.0 in 2023, then slumped by 492.64% to -$3.7 million in 2024, then soared by 39.8% to -$2.2 million in 2025, then sank by 319.75% to -$9.4 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$9.4 million, -$2.2 million, and -$3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Hims & Hers Health | 7.51 Bn | 6.67 Bn | 480.80 Mn | -6.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.34 Mn |
| Mar 31, 2026 | -9.44 Mn |
| Dec 31, 2025 | -2.25 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | -9.65 Mn |
| Mar 31, 2025 | 11.01 Mn |
| Dec 31, 2024 | -3.73 Mn |
| Sep 30, 2024 | -52.00 Mn |
| Jun 30, 2024 | 127,000.00 |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 951,000.00 |
| Sep 30, 2023 | 651,000.00 |
| Jun 30, 2023 | -13,000.00 |
| Mar 31, 2023 | 386,000.00 |
| Dec 31, 2022 | -121,000.00 |
| Sep 30, 2022 | -16,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 94,000.00 |
| Dec 31, 2021 | -87,000.00 |
| Sep 30, 2021 | -3.17 Mn |